165 related articles for article (PubMed ID: 29984593)
1. Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.
Nance RM; Crane HM; Ritchings C; Rosenblatt L; Budoff M; Heckbert SR; Drozd DR; Mathews WC; Geng E; Hunt PW; Feinstein MJ; Moore RD; Hsue P; Eron JJ; Burkholder GA; Rodriguez B; Mugavero MJ; Saag MS; Kitahata MM; Delaney JAC
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):916-921. PubMed ID: 29984593
[TBL] [Abstract][Full Text] [Related]
2. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.
Crane HM; Nance RM; Whitney BM; Heckbert SR; Budoff M; High K; Landay A; Feinstein M; Moore RD; Mathews WC; Christopoulos K; Saag MS; Willig A; Eron JJ; Kitahata MM; Delaney JAC;
J Acquir Immune Defic Syndr; 2021 Feb; 86(2):208-212. PubMed ID: 33433123
[TBL] [Abstract][Full Text] [Related]
4. Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.
Drumright LN; Nance RM; Ruderman SA; Ma J; Whitney BM; Hahn A; Fredericksen RJ; Luu B; Lober WB; Moore RD; Budoff MJ; Keruly JC; Christopoulos K; Puryear S; Willig A; Cropsey K; Mathews WC; Cachay E; Bamford L; Eron JJ; Napravnik S; Mayer KH; O'Cleirigh C; Mccaul ME; Chander G; Feinstein MJ; Saag MS; Kitahata MM; Heckbert SR; Crane HM; Delaney JAC
HIV Med; 2023 Jun; 24(6):703-715. PubMed ID: 36855253
[TBL] [Abstract][Full Text] [Related]
5. Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.
Crane HM; Nance RM; Heckbert SR; Ritchings C; Rosenblatt L; Budoff M; Wood BR; Tirschwell DL; Kim HN; Mathews WC; Geng E; Moore RD; Hunt PW; Eron JJ; Burkholder GA; Drozd DR; Chow FC; Becker KJ; Zunt JR; Ho EL; Kalani R; Huffer A; Whitney BM; Saag MS; Kitahata MM; Delaney JAC
J Acquir Immune Defic Syndr; 2019 Aug; 81(5):e141-e147. PubMed ID: 31135582
[TBL] [Abstract][Full Text] [Related]
6. Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States.
Williams-Nguyen J; Hawes SE; Nance RM; Lindström S; Heckbert SR; Kim HN; Mathews WC; Cachay ER; Budoff M; Hurt CB; Hunt PW; Geng E; Moore RD; Mugavero MJ; Peter I; Kitahata MM; Saag MS; Crane HM; Delaney JA
Am J Epidemiol; 2020 Jun; 189(6):554-563. PubMed ID: 31712804
[TBL] [Abstract][Full Text] [Related]
7. Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.
Lee WJ; Cheng H; Whitney BM; Nance RM; Britton SR; Jordahl K; Lindstrom S; Ruderman SA; Kitahata MM; Saag MS; Willig AL; Burkholder G; Eron JJ; Kovacic JC; Björkegren JLM; Mathews WC; Cachay E; Feinstein MJ; Budoff M; Hunt PW; Moore RD; Keruly J; McCaul ME; Chander G; Webel A; Mayer KH; Delaney JA; Crane PK; Martinez C; Crane HM; Hao K; Peter I
Int J Cardiol; 2023 Jul; 383():15-23. PubMed ID: 37149004
[TBL] [Abstract][Full Text] [Related]
8. Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States.
Crane HM; Paramsothy P; Drozd DR; Nance RM; Delaney JA; Heckbert SR; Budoff MJ; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Crane PK; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Rodriguez C; Peter I; Barnes GS; McReynolds J; Lober WB; Crothers K; Feinstein MJ; Grunfeld C; Saag MS; Kitahata MM;
JAMA Cardiol; 2017 Mar; 2(3):260-267. PubMed ID: 28052152
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
[TBL] [Abstract][Full Text] [Related]
10. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
Díaz-Garzón J; Sandoval Y; Smith SW; Love S; Schulz K; Thordsen SE; Johnson BK; Driver B; Jacoby K; Carlson MD; Dodd KW; Moore J; Scott NL; Bruen CA; Hatch R; Apple FS
Clin Chem; 2017 Jan; 63(1):415-419. PubMed ID: 27811209
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.
Nestelberger T; Boeddinghaus J; Lopez-Ayala P; Kaier TE; Marber M; Gysin V; Koechlin L; Sanchez AY; Giménez MR; Wussler D; Walter JE; Strebel I; Zimmermann T; Glarner N; Miró Ò; Martin-Sanchez FJ; Zehnder T; Twerenbold R; Keller DI; Mueller C;
JAMA Cardiol; 2021 Jul; 6(7):771-780. PubMed ID: 33881449
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
[TBL] [Abstract][Full Text] [Related]
13. Chronic obstructive pulmonary disease and the risk for myocardial infarction by type in people with HIV.
Crothers K; Nance RM; Whitney BM; Harding BN; Heckbert SR; Budoff MJ; Mathews WC; Bamford L; Cachay ER; Eron JJ; Napravnik S; Moore RD; Keruly JC; Willig A; Burkholder G; Feinstein MJ; Saag MS; Kitahata MM; Crane HM; Delaney JAC;
AIDS; 2023 Apr; 37(5):745-752. PubMed ID: 36728918
[TBL] [Abstract][Full Text] [Related]
14. Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV.
Elion RA; Althoff KN; Zhang J; Moore RD; Gange SJ; Kitahata MM; Crane HM; Drozd DR; Stein JH; Klein MB; Eron JJ; Silverberg MJ; Mathews WC; Justice AC; Sterling TR; Rabkin CS; Mayor AM; Klein DB; Horberg MA; Bosch RJ; Eyawo O; Palella FJ;
J Acquir Immune Defic Syndr; 2018 May; 78(1):62-72. PubMed ID: 29419568
[TBL] [Abstract][Full Text] [Related]
15. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
[TBL] [Abstract][Full Text] [Related]
17. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
[TBL] [Abstract][Full Text] [Related]
20. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
Kassem M; Ayala PL; Andric-Cancarevic T; Tajsic M; Vargas KG; Bendik D; Kaufmann C; Wojta J; Mueller C; Huber K
Int J Cardiol; 2024 May; 403():131879. PubMed ID: 38369132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
